JP2022500433A5 - - Google Patents
Info
- Publication number
- JP2022500433A5 JP2022500433A5 JP2021514073A JP2021514073A JP2022500433A5 JP 2022500433 A5 JP2022500433 A5 JP 2022500433A5 JP 2021514073 A JP2021514073 A JP 2021514073A JP 2021514073 A JP2021514073 A JP 2021514073A JP 2022500433 A5 JP2022500433 A5 JP 2022500433A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- compound
- solid form
- pharmaceutical composition
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025137091A JP2025179092A (ja) | 2018-09-13 | 2025-08-20 | Betブロモドメイン阻害剤の固体形態の製造方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862730849P | 2018-09-13 | 2018-09-13 | |
| US62/730,849 | 2018-09-13 | ||
| PCT/IB2019/001011 WO2020053657A1 (en) | 2018-09-13 | 2019-09-13 | Method of manufacturing a solid form of a bet bromodomain inhibitor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025137091A Division JP2025179092A (ja) | 2018-09-13 | 2025-08-20 | Betブロモドメイン阻害剤の固体形態の製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022500433A JP2022500433A (ja) | 2022-01-04 |
| JP2022500433A5 true JP2022500433A5 (cg-RX-API-DMAC7.html) | 2022-09-20 |
| JP7731794B2 JP7731794B2 (ja) | 2025-09-01 |
Family
ID=69777480
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021514073A Active JP7731794B2 (ja) | 2018-09-13 | 2019-09-13 | Betブロモドメイン阻害剤の固体形態の製造方法 |
| JP2025137091A Pending JP2025179092A (ja) | 2018-09-13 | 2025-08-20 | Betブロモドメイン阻害剤の固体形態の製造方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025137091A Pending JP2025179092A (ja) | 2018-09-13 | 2025-08-20 | Betブロモドメイン阻害剤の固体形態の製造方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US12145932B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3849980B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7731794B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210080373A (cg-RX-API-DMAC7.html) |
| CN (1) | CN112955449B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019338059B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3111527A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA202190598A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3034982T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL281258B2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021002885A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202102497SA (cg-RX-API-DMAC7.html) |
| TW (1) | TWI882964B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020053657A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI882964B (zh) | 2018-09-13 | 2025-05-11 | 大陸商恒翼生物醫藥(上海)股份有限公司 | Bet 溴結構域(bromodomain)抑制劑之固體形式之製備方法 |
| TW202327594A (zh) | 2021-09-23 | 2023-07-16 | 大陸商恒翼生物醫藥(上海)股份有限公司 | 用bet溴結構域抑制劑和parp抑制劑的組合治療預選患者群體的三陰性乳腺癌的方法 |
| KR102619331B1 (ko) * | 2021-11-30 | 2023-12-29 | 주식회사 베노바이오 | Bet 단백질을 저해하는 신규한 카르복스아마이드 리독스 유도체 및 이를 이용한 안과질환 예방 및 치료용 조성물 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0919434D0 (en) | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
| CN105473581B (zh) | 2013-06-21 | 2019-04-23 | 齐尼思表观遗传学有限公司 | 作为溴结构域抑制剂的新取代的双环化合物 |
| KR102307566B1 (ko) * | 2013-06-21 | 2021-10-05 | 제니쓰 에피제네틱스 리미티드 | 신규한 바이사이클릭 브로모도메인 억제제 |
| BR122019007990B1 (pt) | 2013-11-18 | 2021-05-04 | Forma Therapeutics, Inc | Composto, e, composição farmacêutica |
| CA2966452A1 (en) | 2014-12-17 | 2016-06-23 | Samuel David Brown | Substituted bicyclic compounds as bromodomain inhibitors |
| WO2017075377A1 (en) * | 2015-10-29 | 2017-05-04 | Incyte Corporation | Amorphous solid form of a bet protein inhibitor |
| CN109715625B (zh) * | 2016-06-20 | 2022-04-19 | 因赛特公司 | Bet抑制剂的结晶固体形式 |
| WO2018097977A1 (en) | 2016-11-22 | 2018-05-31 | Gilead Sciences, Inc. | Crystalline forms of a phosphate complex of a bet inhibitor |
| TWI816880B (zh) | 2018-09-13 | 2023-10-01 | 大陸商恒翼生物醫藥(上海)股份有限公司 | 治療前列腺癌之組合療法 |
| TWI841598B (zh) | 2018-09-13 | 2024-05-11 | 大陸商恒翼生物醫藥(上海)股份有限公司 | 用於治療雌激素受體陽性乳癌之組合療法 |
| TWI882964B (zh) | 2018-09-13 | 2025-05-11 | 大陸商恒翼生物醫藥(上海)股份有限公司 | Bet 溴結構域(bromodomain)抑制劑之固體形式之製備方法 |
-
2019
- 2019-09-12 TW TW108133099A patent/TWI882964B/zh active
- 2019-09-13 EA EA202190598A patent/EA202190598A1/ru unknown
- 2019-09-13 ES ES19860308T patent/ES3034982T3/es active Active
- 2019-09-13 CA CA3111527A patent/CA3111527A1/en active Pending
- 2019-09-13 WO PCT/IB2019/001011 patent/WO2020053657A1/en not_active Ceased
- 2019-09-13 KR KR1020217010933A patent/KR20210080373A/ko active Pending
- 2019-09-13 US US17/275,465 patent/US12145932B2/en active Active
- 2019-09-13 IL IL281258A patent/IL281258B2/en unknown
- 2019-09-13 EP EP19860308.6A patent/EP3849980B1/en active Active
- 2019-09-13 JP JP2021514073A patent/JP7731794B2/ja active Active
- 2019-09-13 CN CN201980060128.8A patent/CN112955449B/zh active Active
- 2019-09-13 MX MX2021002885A patent/MX2021002885A/es unknown
- 2019-09-13 AU AU2019338059A patent/AU2019338059B2/en active Active
- 2019-09-13 SG SG11202102497SA patent/SG11202102497SA/en unknown
- 2019-09-13 EP EP25161539.9A patent/EP4588919A1/en active Pending
-
2024
- 2024-10-09 US US18/910,093 patent/US20250034142A1/en active Pending
-
2025
- 2025-08-20 JP JP2025137091A patent/JP2025179092A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI576343B (zh) | 5-氯-n2-(2-異丙氧基-5-甲基-4-六氫吡啶-4-基-苯基)-n4-[2-(丙烷-2-磺醯基)-苯基]-嘧啶-2,4-二胺之結晶型式 | |
| TWI697495B (zh) | 科帕利普(copanlisib)及其二鹽酸鹽之合成 | |
| CN104024262B (zh) | 埃克替尼和盐酸埃克替尼的制备方法及其中间体 | |
| US20250034142A1 (en) | Method of manufacturing a solid form of a bet bromodomain inhibitor | |
| CN103570633B (zh) | 吉非替尼的制备方法 | |
| TW201625633A (zh) | 科帕利普(copanlisib)及其二鹽酸鹽之合成 | |
| CN105517992A (zh) | 新型结晶性芳烷基胺化合物及其制造方法 | |
| CN104151359A (zh) | 喹唑啉类化合物及其制备方法和在制备酪氨酸激酶抑制剂中的应用 | |
| CN112279838B (zh) | 一种吡咯替尼的制备方法 | |
| BR112021005274A2 (pt) | métodos para produção de compostos de pirazol | |
| JP6594333B2 (ja) | Hx塩の形態の(e)−4−n,n−ジアルキルアミノクロトン酸の製造方法、およびegfrチロシンキナーゼ阻害剤の合成のためのその使用 | |
| WO2019037591A1 (zh) | 盐酸美法仑晶型及其制备方法与应用 | |
| CN108329236B (zh) | 一种恩杂鲁胺中间体的制备方法 | |
| JP2015038053A (ja) | 4−(2−メチル−1−イミダゾリル)−2,2−フェニルブタンアミドの製造方法 | |
| WO2022135300A1 (zh) | 1-苄基-4-甲基-5-烷氧基-1,2,3,6-四氢吡啶衍生物的合成及应用 | |
| JP2022552329A5 (cg-RX-API-DMAC7.html) | ||
| CN119552161B (zh) | 图卡替尼中间体4-([1,2,4]三唑并[1,5-a]吡啶-7-氧基)-3-甲基苯胺的制备工艺 | |
| CN111499622A (zh) | 一种治疗胆管癌的药物的制备方法 | |
| HK40053356B (en) | Method of manufacturing a solid form of a bet bromodomain inhibitor | |
| CN115785081A (zh) | 一种雷替曲塞的制备方法 | |
| HK40053356A (en) | Method of manufacturing a solid form of a bet bromodomain inhibitor | |
| EP1907379A1 (en) | Crystalline forms of (2r-trans)-6-chloro-5ýý4-ý(4-fluorophenyl)methyl¨-2,5-dimethyl-1-piperazinyl¨carbonyl¨-n,n, 1-trimethyl-alpha-oxo-1h-indole-3-acetamide monohydrochloride | |
| TW200948783A (en) | Process for producing compound having NPYY5 receptor antagonism and useful crystals |